Your browser is no longer supported. Please, upgrade your browser.
Settings
ALKS Alkermes plc daily Stock Chart
ALKS [NASD]
Alkermes plc
Index- P/E- EPS (ttm)-1.11 Insider Own0.80% Shs Outstand154.91M Perf Week-3.29%
Market Cap8.83B Forward P/E140.12 EPS next Y0.41 Insider Trans-10.46% Shs Float152.46M Perf Month9.27%
Income-169.30M PEG- EPS next Q0.19 Inst Own- Short Float7.57% Perf Quarter11.63%
Sales841.50M P/S10.50 EPS this Y9.60% Inst Trans2.79% Short Ratio11.30 Perf Half Y-0.87%
Book/sh7.73 P/B7.38 EPS next Y825.00% ROA-9.80% Target Price60.58 Perf Year1.69%
Cash/sh2.91 P/C19.63 EPS next 5Y1.20% ROE-14.10% 52W Range46.42 - 63.40 Perf YTD4.20%
Dividend- P/FCF- EPS past 5Y-6.80% ROI-13.60% 52W High-10.05% Beta2.02
Dividend %- Quick Ratio2.70 Sales past 5Y13.80% Gross Margin82.00% 52W Low22.84% ATR1.46
Employees1750 Current Ratio3.10 Sales Q/Q20.60% Oper. Margin-21.10% RSI (14)60.13 Volatility2.41% 2.52%
OptionableYes Debt/Eq0.24 EPS Q/Q42.90% Profit Margin-20.10% Rel Volume0.70 Prev Close56.12
ShortableYes LT Debt/Eq0.23 EarningsJan 25 BMO Payout- Avg Volume1.02M Price57.03
Recom2.50 SMA203.32% SMA508.71% SMA2005.00% Volume716,716 Change1.62%
Oct-16-17Downgrade Barclays Overweight → Equal Weight $66 → $50
Jun-13-17Downgrade Leerink Partners Outperform → Mkt Perform
Oct-21-16Upgrade JP Morgan Neutral → Overweight
Oct-21-16Reiterated Leerink Partners Outperform $57 → $70
Oct-21-16Reiterated Jefferies Buy $62 → $70
Oct-04-16Resumed Leerink Partners Outperform $57
Jan-21-16Reiterated Leerink Partners Outperform $84 → $58
Jan-21-16Downgrade Morgan Stanley Overweight → Underweight
Jan-21-16Downgrade JP Morgan Overweight → Neutral
Oct-07-15Reiterated Barclays Overweight $77 → $79
Sep-01-15Upgrade Morgan Stanley Underweight → Overweight
Jun-09-15Initiated Guggenheim Neutral
May-21-15Initiated Barclays Overweight $74
Jan-08-15Reiterated Mizuho Buy $72 → $81
Jul-31-14Reiterated Mizuho Buy $61 → $59
Apr-10-14Upgrade Mizuho Neutral → Buy $55 → $61
Apr-09-14Reiterated MKM Partners Sell $32 → $35
Feb-28-14Reiterated UBS Neutral $42 → $53
Feb-28-14Reiterated MKM Partners Sell $26 → $32
Feb-28-14Reiterated Mizuho Neutral $33 → $56
Jan-18-18 01:55PM  3 Biotech Stocks Start Healthy in 18: Will the Rally Last? InvestorPlace
01:00PM  The Klein Law Firm Reminds Investors of a Class Action on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018 (ALKS) ACCESSWIRE
10:27AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline- January 22, 2018 ACCESSWIRE
Jan-17-18 08:47PM  Netflix, Inc. (NFLX), General Electric Company (GE): Mott Capital Managements Top Winners and Losers of 2017 Insider Monkey
06:08PM  ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm Business Wire
04:36PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 - ALKS ACCESSWIRE
02:34PM  FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc (Nasdaq: ALKS) To Contact The Firm GlobeNewswire
01:12PM  Scott+Scott, Attorneys at Law, LLP Reminds Investors of January 22 Deadline in Securities Class Action Against Alkermes plc (ALKS) Business Wire
08:23AM  BlackRock, Pier One Imports, Alkermes, Vertex Pharmaceuticals and Agenus highlighted as Zacks Bull and Bear of the Day Zacks
Jan-16-18 03:11PM  3 Biotech Stocks Start Healthy in '18: Will the Rally Last? Zacks
11:34AM  ALKS UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018 ACCESSWIRE
10:34AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline- January 22, 2018 ACCESSWIRE
Jan-15-18 11:00AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 - ALKS ACCESSWIRE
08:15AM  3 Pharma and Biotech Stocks to Watch Out for in 2018 Zacks
Jan-13-18 08:29AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
Jan-12-18 08:08AM  See what the IHS Markit Score report has to say about Alkermes PLC. Markit
Jan-11-18 08:00PM  The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018 GlobeNewswire
Jan-10-18 06:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
03:00PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 - ALKS ACCESSWIRE
Jan-09-18 06:23PM  ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm Business Wire +5.65%
02:07PM  Alkermes Is Getting Ready for a Rally TheStreet.com
11:34AM  ALKS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018 GlobeNewswire
10:33AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline- January 22, 2018 ACCESSWIRE
08:08AM  See what the IHS Markit Score report has to say about Alkermes PLC. Markit
06:36AM  Alkermes: Cramer's Top Takeaways TheStreet.com
Jan-08-18 07:23PM  Alkermes CEO: 'Best days are still ahead' for opioid addi... CNBC Videos
07:02PM  Cramer Remix: Teslas stock is up for one simple reason CNBC Videos
06:55PM  'Best days are still ahead' for top opioid addiction trea... CNBC Videos
06:42PM  'Best days are still ahead' for top opioid addiction treatment Vivitrol, CEO says CNBC
04:00PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 ALKS GlobeNewswire
08:08AM  See what the IHS Markit Score report has to say about Alkermes PLC. Markit
Jan-06-18 07:44AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
Jan-05-18 05:09PM  Primecap Management Keeps Buying Alkermes GuruFocus.com
11:45AM  The Klein Law Firm Notifies Investors of a Class Action Commenced on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018 ACCESSWIRE
10:33AM  SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline: January 22, 2018 ACCESSWIRE
07:13AM  [$$] Primecap: Two Stocks It's Buying, One It's Selling Barrons.com
Jan-02-18 04:00PM  Alkermes' Corporate Presentation to be Webcast at the 36th Annual J.P. Morgan Healthcare Conference PR Newswire
02:40PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 - ALKS ACCESSWIRE
08:08AM  See what the IHS Markit Score report has to say about Alkermes PLC. Markit
Dec-30-17 06:56AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
Dec-28-17 02:13PM  ALKS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018 ACCESSWIRE
10:09AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline: January 22, 2018 ACCESSWIRE
05:45AM  Does Alkermes plcs (NASDAQ:ALKS) Latest Financial Perfomance Look Strong? Simply Wall St.
Dec-27-17 08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
01:23PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 - ALKS ACCESSWIRE
Dec-23-17 08:15AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline ALKS Business Wire
Dec-21-17 12:05PM  The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
Dec-20-17 04:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
01:00PM  ALKS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
Dec-19-17 05:20PM  ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm ACCESSWIRE
10:09AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
03:00AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
Dec-18-17 03:05PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
02:45PM  The Klein Law Firm Announces a Class Action Commenced on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
Dec-16-17 08:40AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS PR Newswire
Dec-14-17 02:30AM  The Klein Law Firm Announces a Class Action Filed on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018 GlobeNewswire
Dec-13-17 04:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
02:00AM  ALKS INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
Dec-12-17 12:10PM  Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of Securities Class Action Against Alkermes plc (ALKS) PR Newswire
10:08AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
02:00AM  ALKS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018 GlobeNewswire
Dec-11-17 02:55PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
02:15PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
11:14AM  Cramer's lightning round: Auto stocks like GM are not my ... CNBC Videos
Dec-09-17 08:30AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline ALKS GlobeNewswire
Dec-08-17 08:08AM  See what the IHS Markit Score report has to say about Alkermes PLC. Markit
Dec-07-17 02:30PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alkermes plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 ALKS GlobeNewswire
08:34AM  Surging Earnings Estimates Signal Good News for Alkermes (ALKS) Zacks
Dec-06-17 06:49PM  Robbins Arroyo LLP: Alkermes plc (ALKS) Misled Shareholders According to a Recently Filed Class Action Business Wire
Dec-05-17 04:31PM  Primecap Management Buys Alkermes Biopharma GuruFocus.com
01:46PM  The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Alkermes plc Business Wire
10:07AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Dec-04-17 03:30PM  The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Alkermes plc Business Wire
Dec-02-17 09:13AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
Dec-01-17 06:03PM  ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm PR Newswire
04:07PM  ALKS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Alkermes plc Business Wire
10:05AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Nov-30-17 03:00PM  ALKS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Alkermes plc Business Wire
02:26PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc (Nasdaq: ALKS) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
Nov-29-17 04:23PM  Biogen Acquires Worldwide License for Alkermes' MS Candidate (revised) Zacks
12:35PM  Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of a Securities Class Action Against Alkermes plc (ALKS) Business Wire
08:08AM  See what the IHS Markit Score report has to say about Alkermes PLC. Markit
08:08AM  Biotech Stock Roundup: Regeneron Down on Eylea Data, Biogen-Alkermes in MS Deal Zacks
Nov-28-17 04:45PM  Biogen Acquires Worldwide License for Alkermes' MS Candidate Zacks
03:17PM  Biogen's Next Big Drug Is Barrons.com
09:38AM  Recent lawsuits claim Alkermes fired female workers who complained of bias American City Business Journals
08:07AM  See what the IHS Markit Score report has to say about Alkermes PLC. Markit
03:18AM  Why Is Alkermes (ALKS) Down 8.3% Since the Last Earnings Report? Zacks
Nov-27-17 04:21PM  Is Biogen's Multiple Sclerosis Franchise Getting A New Lease On Life? Investor's Business Daily
03:53PM  Biogen Inc. Buys Its Way Out of Competition Motley Fool
02:27PM  Biogen: If You Can't Beat 'em Barrons.com
02:21PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Alkermes plc Business Wire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline - January 22, 2018 PR Newswire
10:04AM  Biogen boosts multiple sclerosis holding with Alkermes license Reuters
09:49AM  Stocks to Watch: Amazon, Time, Alkermes, Biogen, SandRidge, Barracuda Networks The Wall Street Journal
09:30AM  Alkermes Jumps on License Deal With Biogen -- Biotech Movers TheStreet.com
08:50AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS ACCESSWIRE
08:48AM  UPDATE: Alkermes shares rise 6% on Biogen multiple sclerosis drug partnership MarketWatch
07:33AM  Alkermes Plc breached its 50 day moving average in a Bullish Manner : ALKS-US : November 27, 2017 Capital Cube
07:00AM  Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis Business Wire
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. The company's marketed products include ARISTADA (aripiprazole lauroxil) for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA for treating schizophrenia; AMPYRA (dalfampridine)/FAMPYRA (fampridine) to enhance walking in adults with multiple sclerosis who have walking disability; and BYDUREON (exenatide extended-release for injectable suspension) for the treatment of type 2 diabetes. It is also developing ALKS 5461 that is in Phase III clinical trials for the treatment of depressive disorder; ALKS 3831, which is in Phase III clinical trials to treat schizophrenia; ALKS 8700, a monomethyl fumarate molecule, which is in Phase III clinical trials to treat multiple sclerosis; ALKS 6428, which is in Phase III clinical trials to help physicians transition patients from physical dependence on opioids; and Aripiprazole lauroxil, an injectable atypical antipsychotic, which has completed a Phase I clinical trials for the treatment of schizophrenia, as well as ALKS 4230, a cell activator that is in Phase I clinical trials for cancer immunotherapy. The company serves pharmaceutical wholesalers, and specialty pharmacies and distributors. It has collaboration agreements with Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cooke ShanePresident, Alkermes plcJan 11Option Exercise16.556,207102,72680,915Jan 16 06:30 PM
Cooke ShanePresident, Alkermes plcJan 11Sale60.226,207373,80974,708Jan 16 06:30 PM
MITCHELL PAUL JDirectorJan 02Option Exercise11.441,00011,4409,000Jan 03 05:11 PM
MITCHELL PAUL JDirectorJan 02Sale54.991,00054,9908,000Jan 03 05:11 PM
Brown Iain MichaelSVP Finance & CAO, Alks Inc.Dec 29Sale54.8110,652583,88616,943Jan 02 06:28 PM
ANSTICE DAVID WDirectorDec 13Option Exercise11.4440,000457,60055,000Dec 14 05:26 PM
MITCHELL PAUL JDirectorDec 01Option Exercise11.441,00011,4409,000Dec 01 05:32 PM
MITCHELL PAUL JDirectorDec 01Sale51.981,00051,9808,000Dec 01 05:32 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSNov 29Option Exercise12.2920,932257,254164,971Nov 30 06:18 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSNov 29Sale50.5120,9321,057,249144,039Nov 30 06:18 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSNov 08Option Exercise12.2920,932257,254164,971Nov 09 05:07 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSNov 08Sale47.5820,932996,009144,039Nov 09 05:07 PM
POPS RICHARD FDirector and CEO, Alkermes plcNov 02Option Exercise14.1350,000706,500687,686Nov 03 05:19 PM
POPS RICHARD FDirector and CEO, Alkermes plcNov 02Sale48.8750,0002,443,410637,686Nov 03 05:19 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.Nov 01Option Exercise14.1315,000211,950178,693Nov 03 05:13 PM
MITCHELL PAUL JDirectorNov 01Option Exercise11.441,00011,4409,000Nov 03 05:17 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.Nov 01Sale48.7115,000730,688163,693Nov 03 05:13 PM
MITCHELL PAUL JDirectorNov 01Sale49.161,00049,1608,000Nov 03 05:17 PM
MITCHELL PAUL JDirectorOct 02Option Exercise11.441,50017,1609,500Oct 04 05:06 PM
MITCHELL PAUL JDirectorOct 02Sale50.641,50075,9608,000Oct 04 05:06 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSSep 15Option Exercise15.475,80589,77461,589Sep 18 06:08 PM
Gaffin David JosephSVP, CLO, Alkermes, Inc.Sep 15Option Exercise14.132503,53331,407Sep 18 05:13 PM
BLOOM FLOYD EDirectorSep 12Option Exercise11.4420,000228,80020,000Sep 14 05:22 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSSep 11Option Exercise14.1313,566191,68870,455Sep 13 05:36 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSSep 11Sale51.2913,566695,81756,889Sep 13 05:36 PM
MITCHELL PAUL JDirectorSep 01Option Exercise11.441,50017,1609,500Sep 05 05:09 PM
MITCHELL PAUL JDirectorSep 01Sale50.771,50076,1558,000Sep 05 05:09 PM
MITCHELL PAUL JDirectorAug 01Option Exercise11.441,50017,1609,500Aug 01 05:12 PM
MITCHELL PAUL JDirectorAug 01Sale54.911,50082,3658,000Aug 01 05:12 PM
MITCHELL PAUL JDirectorJul 03Option Exercise11.441,50017,1609,500Jul 06 05:36 PM
MITCHELL PAUL JDirectorJul 03Sale58.111,50087,1658,000Jul 06 05:36 PM
Cooke ShanePresident, Alkermes plcJun 08Option Exercise16.5510,000165,50084,708Jun 08 05:33 PM
Stejbach MarkSVP/Chief Comm Off, Alks IncJun 08Option Exercise17.3010,000173,00054,013Jun 08 05:41 PM
Stejbach MarkSVP/Chief Comm Off, Alks IncJun 08Sale60.3410,000603,35244,013Jun 08 05:41 PM
Cooke ShanePresident, Alkermes plcJun 08Sale60.3310,000603,33374,708Jun 08 05:33 PM
MITCHELL PAUL JDirectorJun 01Option Exercise11.441,50017,1609,500Jun 01 05:21 PM
MITCHELL PAUL JDirectorJun 01Sale57.491,50086,2358,000Jun 01 05:21 PM
Stejbach MarkSVP/Chief Comm Off, Alks IncMay 28Option Exercise0.002,500044,013May 30 05:51 PM
POPS RICHARD FDirector and CEO, Alkermes plcMay 28Option Exercise0.0013,7500644,156May 30 05:49 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.May 28Option Exercise0.002,5000164,870May 30 05:46 PM
Gaffin David JosephSVP, CLO, Alkermes, Inc.May 28Option Exercise0.001,250031,563May 30 05:42 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSMay 28Option Exercise0.002,5000130,654May 30 05:39 PM
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.May 28Option Exercise0.003,750058,821May 30 05:30 PM
Cooke ShanePresident, Alkermes plcMay 28Option Exercise0.005,750077,698May 30 05:23 PM
Brown Iain MichaelSVP Finance & CAO, Alks Inc.May 28Option Exercise0.001,750028,163May 30 05:20 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSMay 28Option Exercise0.003,750058,654May 30 05:16 PM
POPS RICHARD FDirector and CEO, Alkermes plcMay 24Option Exercise15.9525,000398,750655,406May 25 05:34 PM
POPS RICHARD FDirector and CEO, Alkermes plcMay 24Sale57.4225,0001,435,535630,406May 25 05:34 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.May 18Option Exercise15.9510,000159,500172,370May 19 05:58 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.May 18Sale57.2310,000572,254162,370May 19 05:58 PM
POPS RICHARD FDirector and CEO, Alkermes plcMay 17Option Exercise15.9550,000797,500680,406May 19 05:28 PM
Gaffin David JosephSVP, CLO, Alkermes, Inc.May 17Option Exercise15.952,25035,88830,313May 19 05:19 PM
POPS RICHARD FDirector and CEO, Alkermes plcMay 17Sale58.1950,0002,909,439630,406May 19 05:28 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.May 11Option Exercise15.9510,000159,500172,370May 11 05:06 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.May 11Sale57.0110,000570,082162,370May 11 05:06 PM
POPS RICHARD FDirector and CEO, Alkermes plcMay 10Option Exercise15.9525,000398,750655,406May 11 05:03 PM
POPS RICHARD FDirector and CEO, Alkermes plcMay 10Sale57.2925,0001,432,244630,406May 11 05:03 PM
Cooke ShanePresident, Alkermes plcMay 04Option Exercise16.556,500107,57578,448May 04 05:26 PM
Cooke ShanePresident, Alkermes plcMay 04Sale60.056,500390,32871,948May 04 05:26 PM
MITCHELL PAUL JDirectorMay 01Option Exercise11.441,50017,1609,500May 03 05:19 PM
Cooke ShanePresident, Alkermes plcMay 01Option Exercise16.553,50057,92575,448May 03 05:30 PM
Cooke ShanePresident, Alkermes plcMay 01Sale60.053,500210,16571,948May 03 05:30 PM
MITCHELL PAUL JDirectorMay 01Sale58.741,50088,1108,000May 03 05:19 PM
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.Apr 17Option Exercise16.5510,000165,50065,071Apr 18 05:13 PM
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.Apr 17Sale56.6010,000565,98655,071Apr 18 05:13 PM
MITCHELL PAUL JDirectorApr 03Option Exercise11.441,50017,1609,500Apr 04 05:12 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSApr 03Option Exercise15.9515,000239,25069,904Apr 04 05:28 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSApr 03Sale57.6815,000865,23454,904Apr 04 05:28 PM
MITCHELL PAUL JDirectorApr 03Sale58.311,50087,4658,000Apr 04 05:12 PM
Cooke ShanePresident, Alkermes plcMar 29Option Exercise16.362,07033,86974,018Mar 29 05:20 PM
Cooke ShanePresident, Alkermes plcMar 29Sale60.002,070124,20071,948Mar 29 05:20 PM
Cooke ShanePresident, Alkermes plcMar 23Option Exercise15.586,03093,94777,978Mar 27 05:32 PM
Cooke ShanePresident, Alkermes plcMar 23Sale60.016,030361,85671,948Mar 27 05:32 PM
Cooke ShanePresident, Alkermes plcMar 21Option Exercise15.701,60025,11573,548Mar 22 06:45 PM
Cooke ShanePresident, Alkermes plcMar 21Sale60.101,60096,16271,948Mar 22 06:45 PM
Cooke ShanePresident, Alkermes plcMar 20Option Exercise15.903004,77072,248Mar 22 06:45 PM
Cooke ShanePresident, Alkermes plcMar 20Sale60.0030018,00071,948Mar 22 06:45 PM
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.Mar 15Option Exercise16.5510,000165,50066,071Mar 16 06:17 PM
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.Mar 15Sale56.7411,000624,10755,071Mar 16 06:17 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSMar 10Option Exercise12.298,137100,00454,904Mar 10 05:13 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSMar 07Option Exercise16.5525,000413,750144,053Mar 07 05:29 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSMar 07Sale59.0825,0001,477,068119,053Mar 07 05:29 PM
Stejbach MarkSVP/Chief Comm Off, Alks IncMar 03Option Exercise0.002,812041,513Mar 06 05:50 PM
POPS RICHARD FDirector and CEO, Alkermes plcMar 03Option Exercise0.0013,0000636,523Mar 06 05:47 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.Mar 03Option Exercise0.002,8120163,283Mar 06 05:42 PM
Gaffin David JosephSVP, CLO, Alkermes, Inc.Mar 03Option Exercise0.001,250028,469Mar 06 05:40 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSMar 03Option Exercise0.002,8120119,966Mar 06 05:37 PM
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.Mar 03Option Exercise0.003,750057,836Mar 06 05:35 PM
Cooke ShanePresident, Alkermes plcMar 03Option Exercise0.005,250074,678Mar 06 05:34 PM
Brown Iain MichaelSVP Finance & CAO, Alks Inc.Mar 03Option Exercise0.001,250026,819Mar 06 05:32 PM
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKSMar 03Option Exercise0.003,500048,414Mar 06 05:31 PM
Cooke ShanePresident, Alkermes plcMar 02Option Exercise14.6020,000292,00089,428Mar 02 05:57 PM
Cooke ShanePresident, Alkermes plcMar 02Sale60.0020,0001,200,00069,428Mar 02 05:57 PM
BREYER ROBERT ADirectorMar 02Sale60.004,000240,0007,156Mar 02 05:53 PM
MITCHELL PAUL JDirectorMar 01Option Exercise11.441,50017,1609,500Mar 02 05:21 PM
Stejbach MarkSVP/Chief Comm Off, Alks IncMar 01Option Exercise0.005,250041,138Mar 02 06:19 PM
POPS RICHARD FDirector and CEO, Alkermes plcMar 01Option Exercise0.0017,5000631,757Mar 02 06:17 PM
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.Mar 01Option Exercise0.004,5000161,932Mar 02 06:15 PM
Gaffin David JosephSVP, CLO, Alkermes, Inc.Mar 01Option Exercise0.002,250027,950Mar 02 06:07 PM
FRATES JAMES MSVP, Alks Inc; CFO ALKSMar 01Option Exercise0.004,5000118,615Mar 02 06:04 PM